Skip to content
healthcare.dev

Ibrance

NDC 63539-284, palbociclib, tablet, film coated, from U.S. Pharmaceuticals.

Product NDC
63539-284
Status
Listed
Labeler
U.S. Pharmaceuticals
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA212436
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63539-284 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PALBOCICLIB75 mg/1

Pharmacologic classes

Cytochrome P450 3A Inhibitors [MoA]; Kinase Inhibitor [EPC]; Kinase Inhibitors [MoA]

Package NDCNDC-11Package
63539-284-03635390284033 DOSE PACK in 1 CARTON (63539-284-03) / 7 TABLET, FILM COATED in 1 DOSE PACK (63539-284-07)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/89a142d5-7e61-48bf-9e77-e2cd124c4792

Use it

Look up 63539-284 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63539-284 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63539-284. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.